Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Upon the aberrant activation of oncogenes, normal cells can enter the cellular senescence program, a state of stable cell-cycle arrest, which represents an important barrier against tumour development in vivo. Senescent cells communicate with their environment by secreting various cytokines and growth factors, and it was reported that this 'secretory phenotype' can have pro- as well as anti-tumorigenic effects. Here we show that oncogene-induced senescence occurs in otherwise normal murine hepatocytes in vivo. Pre-malignant senescent hepatocytes secrete chemo- and cytokines and are subject to immune-mediated clearance (designated as 'senescence surveillance'), which depends on an intact CD4(+) T-cell-mediated adaptive immune response. Impaired immune surveillance of pre-malignant senescent hepatocytes results in the development of murine hepatocellular carcinomas (HCCs), thus showing that senescence surveillance is important for tumour suppression in vivo. In accordance with these observations, ras-specific Th1 lymphocytes could be detected in mice, in which oncogene-induced senescence had been triggered by hepatic expression of Nras(G12V). We also found that CD4(+) T cells require monocytes/macrophages to execute the clearance of senescent hepatocytes. Our study indicates that senescence surveillance represents an important extrinsic component of the senescence anti-tumour barrier, and illustrates how the cellular senescence program is involved in tumour immune surveillance…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given the proinflammatory nature of the SASP, it is not surprising that senescent cells can attract immune cells, including destructive leukocytes of the innate and adaptive immune systems (131, 132, 135).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Among the cells that participate in the clearance of senescent cells are natural killer cells, macrophages, and T cells (131, 135, 139).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Senescent cells, presumably by virtue of SASP-derived factors, can stimulate the infiltration of leukocytes (93, 131, 132), which produce reactive toxic moieties that can cause DNA damage.”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Another function appears to be the stimulation of a local immune reaction to eliminate oncogene-expressing cells, both those cells that have undergone oncogene-induced senescence and those oncogene-transformed cells that have bypassed or escaped senescence (131).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“The surveillance and clearance of senescent cells by the immune system is necessary in order to limit tumorigenesis in premalignant lesions and following cancer therapy155,156,159.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [156]
39 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801
Self-citationKrtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Khwaja, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2783 · Cited by 1,039
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M., & Jacks, T. (2003) · Nature · doi:10.1038/nature01764 · Cited by 538
Frid, M. G., Brunetti, J. A., Burke, D. L., Carpenter, T. C., Davie, N. J., Reeves, J. T., Roedersheimer, M. T., van Rooijen, N., & Stenmark, K. R. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050599 · Cited by 449
Silva, M. T. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809549 · Cited by 322
Cited by
Items 901–1,000 of 1,009
Puri, N., Uppada, S. B., Erickson, T., Wojdyla, L. M., Moravec, D. N., Song, Z., & Cheng, J. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s55133 · Cited by 20
“Results T-oligo induces senescence and decreases clonogenic capacity in melanoma cells Senescence has been shown to be a key restraining factor in cancer formation and progression.(21) Earlier studies have demonstrated that T-oligo induces senescence in lung and breast”
Identification of a small molecule SR9009 that activates NRF2 to counteract cellular senescence
Gao, L., Wang, Y., Liu, Z., Sun, Y., Cai, P., & Jing, Q. (2021) · Aging Cell · doi:10.1111/acel.13483 · Cited by 22
The Potential of Senescence as a Target for Developing Anticancer Therapy
Jo, H., Shim, K., & Jeoung, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043436 · Cited by 20
“Sci. 2023, 24, 3436 9 of 24 resistance-related gene ABCG2 in hepatocellular carcinoma cells (HCCs) [71].”
BackgroundCellular senescence: from homeostasis to pathological implications and therapeutic strategies
Li, C., Yuan, Y., Jia, Y., Zhou, Q., Wang, Q., & Jiang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1534263 · Cited by 29
Kaplon, J., Cornelia, H.-H., Gao, L. Y., Meissl, K., Verdegaal, E. M. E., van der Burg, S. H., van Doorn, R., & Peeper, D. S. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12248 · Cited by 21
Marongiu, F., Serra, M. P., Sini, M., Angius, F., & Laconi, E. (2014) · Aging · doi:10.18632/aging.100631 · Cited by 21
“The effect was attributed to the putative preneoplastic nature of oncogenetransduced senescent cells, whose removal by a T-cell specific response was therefore considered as directly responsible for the reduced incidence of HCC [40].”
BackgroundCellular senescence associated immune responses in liver cancer
Greten, T. F., & Eggert, T. (2017) · Hepatic Oncology · doi:10.2217/hep-2017-0011 · Cited by 21
Isolation of senescent cells by iodixanol (OptiPrep) density gradient‐based separation
Kovačovicova, K. L., & Vinciguerra, M. (2019) · Cell Proliferation · doi:10.1111/cpr.12674 · Cited by 21
TRIM28/KAP1 regulates senescence
dos Santos, J. C. P. T., & Gil, J. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.08.011 · Cited by 20
Self-citationYamamoto, M., Tanaka, H., Bing, X., Nishikawa, Y., Yamazaki, K., Shimizu, K., & Ogawa, K. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22510 · Cited by 20
Cytokine-induced senescence for cancer surveillance
Wieder, T., Brenner, E., Braumüller, H., Bischof, O., & Röcken, M. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9667-z · Cited by 20
“Oncogene-induced senescence is eventually accompaniedbymacrophage-mediatedremovalof theaffectedcancer cells, and this clearancemechanismof senescent cancers substantially improves the anti-cancer defense machinery of the immunesystem[16].”
BackgroundWeiskirchen, R., & Tacke, F. (2016) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2016.09.10 · Cited by 20
“More recently, adaptive immune cells were recognized in liver cancer for their tumor surveillance function, assigning them an important anti-tumoral role (8,9).”
BackgroundSelf-citationChang, Y., Chen, M., Zhu, H., Liu, R., Hu, Z.-Y., Yang, S.-J., Wang, X., Cheng, Y., Song, Y.-J., Mao, X.-Y., et al. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.139557 · Cited by 19
CD4 T cells acquire Eomesodermin to modulate cellular senescence and aging
Elyahu, Y., Feygin, I., Eremenko, E., Pinkas, N., Zemer, A., Shicht, A., Berner, O., Avigdory-Meiri, R., Nemirovsky, A., Reshef, K., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00953-8 · Cited by 21
Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise
Hinterleitner, C., Goldberg, H. V., McHugh, D., Barthet, V. J. A., Filliol, A. A., & Lowe, S. W. (2026) · Cell · doi:10.1016/j.cell.2026.03.005 · Cited by 24
“Through the SASP, senescent cells can promote immune-mediated clearance of damaged or premalignant cells or, when persistent, drive chronic inflammation, fibrosis, and tumor progression 10,17,65,66 .”
InfluentialLoss of p16: A Bouncer of the Immunological Surveillance?
Leon, K. E., Tangudu, N. K., Aird, K. M., & Buj, R. (2021) · Life · doi:10.3390/life11040309 · Cited by 23
“For example, SASP secretion by senescence hepatocytes promotes T-cell mediated immunological surveillance within the liver, promoting the clearance of pre-malignant senescent cells and hence avoiding tumor progression [83].”
BackgroundSenolysis Reduces Senescence in Veins and Cancer Cell Migration
Estepa‐Fernández, A., Alfonso, M., Morellá‐Aucejo, Á., García‐Fernández, A., Lérida‐Viso, A., Lozano‐Torres, B., Galiana, I., Soriano‐Teruel, P. M., Sancenón, F., Orzáez, M., et al. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100149 · Cited by 20
Wen, C., Tian, Z., Li, L., 瞿述根, Chen, T., Liang, Z., Chen, H., Ying, Y., Dai, J., Li, P., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314832 · Cited by 21
“Regarding the molecular mechanism, for instance, activation of the AKT signaling pathway induces cell proliferation, lipogenesis, and tumor development in HCC [35]; hepatic expression of Nras(G12V) triggers oncogene-induced senescence [36]; coexpression of hMet and mutantβ-catenin activates hMet and Wnt pathways [37],…”
BackgroundMethodOverview of Innate Immune Cell Landscape in Liver Aging
Lin, Y., Li, Q., Liang, G., Xiao, N., Yang, J., Yang, X. M., Zhang, H., Zhang, C., & Liu, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010181 · Cited by 21
“In addition, it has been reported that CD4+ T cells require monocytes/macrophages to execute the killing of senescent hepatocytes, and selective depletion of neutrophils has marginally affected senescence surveillance [61], suggesting that neutrophils might not directly clear senescence cells.”
BackgroundHou, P.-P., Zheng, C.-M., Wu, S.-H., Liu, X.-X., Xiang, G., Cai, W., Chen, G., & Lou, Y. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0832 · Cited by 23
Molecular tools that block maturation of the nuclear lamin A and decelerate cancer cell migration
Matralis, A. N., Xanthopoulos, D., Huot, G., Lopes‐Paciencia, S., Cole, C., de Vries, H., Ferbeyre, G., & Tsantrizos, Y. S. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.10.001 · Cited by 23
Cellular senescence in vivo: From cells to tissues to pathologies
Kumar, A., Bano, D., & Ehninger, D. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111308 · Cited by 20
Hernández‐Mercado, E., Prieto‐Chávez, J. L., Arriaga‐Pizano, L., Hernández-Gutiérrez, S., Mendlovic, F., Königsberg, M., & López‐Díazguerrero, N. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910215 · Cited by 19
Kellers, F., Fernandez, A., Konukiewitz, B., Schindeldecker, M., Tagscherer, K. E., Heintz, A., Jesinghaus, M., Roth, W., & Foersch, S. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.865230 · Cited by 23
“” This immune cell driven clearance of senescent cells involves the innate (41, 42) as well as the adaptive immune cells (43, 44).”
BackgroundMitochondria-driven elimination of cancer and senescent cells
Hubáčková, S., Novais, S. M., Davidová, E., Neužil, J., & Rohlena, J. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0256 · Cited by 20
Madsen, S. D., Jones, S. H., Tucker, H. A., Giler, M. K., Muller, D. C., Discher, C. T., Russell, K. C., Dobek, G. L., Sammarco, M. C., Bunnell, B. A., et al. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27195 · Cited by 19
Zhou, L., DeMarco, K. D., Murphy, K. C., Wu, Z., Li, J., Johnson, C., Liu, B., Giwa, H. K., Ma, B., Bhalerao, N., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-1212 · Cited by 22
CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges
Arsenijevic, T., Coulonval, K., Raspé, E., Demols, A., Roger, P. P., & Laethem, J. V. (2023) · Cancers · doi:10.3390/cancers15030968 · Cited by 21
“This immune response is also elicited by oncogeneinduced senescence [116].”
BackgroundDecreased thymic output predicts progression of chronic kidney disease
Iio, K., Kabata, D., Iio, R., Shibamoto, S., Watanabe, Y., Morita, M., Imai, Y., Hatanaka, M., Omori, H., & Isaka, Y. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00333-z · Cited by 19
Papaspyropoulos, A., Hazapis, O. G., Altulea, A., Polyzou, A., Verginis, P., Evangelou, K., Fousteri, M. I., Papantonis, A., Demaria, M., & Gorgoulis, V. G. (2023) · Aging Cell · doi:10.1111/acel.13893 · Cited by 18
Liu, Z., Zhang, Y., Li, D., & Fu, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116463 · Cited by 20
Chen, M., Wu, G., Lu, Y., Sun, S., Zhao, Y., Pan, X., Chen, W., Xu, J., Qiu, H., He, W., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.04.002 · Cited by 19
Castoldi, M., Roy, S., Angendohr, C., Pellegrino, R., Vucur, M., Singer, M. T., Büttner, V., Dille, M. A., Wolf, S. D., Heij, L. R., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.08.025 · Cited by 20
Self-citationSenescence in the ageing skin: a new focus on m TORC 1 and the lysosome
Smith, P., & Carroll, B. (2024) · FEBS Journal · doi:10.1111/febs.17281 · Cited by 21
Cellular senescence and liver disease: Mechanisms and therapeutic strategies
Guo, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.075 · Cited by 20
Senescence as a main mechanism of Ritonavir and Ritonavir‐NO action against melanoma
Paskaš, S., Krajnović, T., Basile, M. S., Đunđerović, D., Cavalli, E., Mangano, K., Mammana, S., Al‐Abed, Y., Nicoletti, F., Mijatović, S., et al. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23020 · Cited by 18
“Nevertheless, senescent cells can be cleared in vivo by an immune system.(45,53) Here, we present a novel mechanism of two HIV‐PIs, Ritonavir and its NO‐derivative.”
Aging-Related Molecular Pathways in Chronic Cholestatic Conditions
Pinto, C., Ninfole, E., Benedetti, A., Maroni, L., & Marzioni, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2019.00332 · Cited by 18
“In vivo data have shown the accumulation of senescent cells in aged tissues (33, 34).”
BackgroundGenes and pathways involved in senescence bypass identified by functional genetic screens
Roupakia, E., Markopoulos, G. S., & Kolettas, E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111432 · Cited by 20
Wang, M., Chen, J., Song, S., Su, J., Zhao, L., Liu, Q., Yang, T., Chen, Z., Liu, C., Fu, Z., et al. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s296234 · Cited by 18
Aging and Cancer: The Waning of Community Bonds
Laconi, E., Cheri, S., Fanti, M., & Marongiu, F. (2021) · Cells · doi:10.3390/cells10092269 · Cited by 20
“Both innate and adaptive immune cells can actively eliminate damaged or altered cells through different mechanisms [32].”
BackgroundThe effect of liver disease on hepatic microenvironment and implications for immune therapy
Brown, Z. J., Ruff, S. M., & Pawlik, T. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1225821 · Cited by 20
The innate immune system as mediator of systemic DNA damage responses
Ermolaeva, M., & Schumacher, B. (2013) · Communicative & Integrative Biology · doi:10.4161/cib.26926 · Cited by 21
“In mice, DNA damage-induced IL-6 secretion by thymic epithelial cells establishes a chemo-protective niche for lymphoma cells,(20) while p53-induced cytokine release may induce both innate and adaptive immune responses leading to tumor cell clearance.(21,22) It is thought that DNA damage accumulation with aging causes…”
BackgroundAssessment and consequences of cell senescence in atherosclerosis
Garrido, A. M., & Bennett, M. R. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000327 · Cited by 19
The Dual Role of Senescence in Pancreatic Ductal Adenocarcinoma
Porciuncula, A., Hajdu, C. H., & David, G. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.05.006 · Cited by 20
Coia, H., Ma, N., Hou, Y., Permaul, E., Berry, D. L., Cruz, M. I., Pannkuk, E. L., Girgis, M. J., Zhu, Z., Lee, Y., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.04.033 · Cited by 20
“These results corroborated previous observations that CD4+ T cells play a role in inhibiting HCC development through immune surveillance of hepatocytes [23].”
ResultTherapy-induced senescence — an induced synthetic lethality in liver cancer?
Wolter, K., & Zender, L. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0262-3 · Cited by 18
Self-citationFeng, D., Shi, X., You, J., Xiong, Q., Zhu, W., Wei, Q., & Yang, L. (2022) · PubMed · Cited by 20
The microbiota and aging microenvironment in pancreatic cancer: Cell origin and fate
Chen, Z., Wang, Z., Du, Y., Shi, H., & Zhou, W. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188826 · Cited by 17
Wuestefeld, A., Iakovleva, V., Yap, S. X. L., Ong, A. B. L., Huang, D. Q., Shuen, T. W. H., Toh, H. C., Dan, Y. Y., Zender, L., & Wüestefeld, T. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1477 · Cited by 18
“At later time points, time-course analysis revealed a rapid loss of Nras-positive cells due to immune clearance (10).”
InfluentialSelf-citationThe dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage
Jin, C., Einig, E., Xu, W., Kollampally, R. B., Schlösser, A., Flentje, M., & Popov, N. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae004 · Cited by 17
“Cell culture and reagents HLF (Cellosaurus ID CVCL_2947) and p19 − / − Nras cells ( 44 ) were provided by Ramona Rudalska (University Hospital Tübingen).”
The Role of Aging and Senescence in Immune Checkpoint Inhibitor Response and Toxicity
Jain, S. S., Sojo, G. B., Sun, H., Friedland, B. N., McNamara, M. E., Schmidt, M. O., & Wellstein, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137013 · Cited by 18
“The accumulation of senescent immune cells in specific tissues may explain the onset of irAEs—indeed, one study demonstrated that T cells could be induced to senescence, characterized by loss of CD27 and CD28, after exposure to tumor cells [104,111].”
BackgroundEssential roles of B cell subsets in the progression of MASLD and HCC
Petriv, N., Suo, H., Hochnadel, I., Timrott, K., Bondarenko, N., Neubert, L., Reinhard, E., Jedicke, N., Kaufhold, P., Guzmán, C. A., et al. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101189 · Cited by 23
Self-citationDecoding T cell senescence in cancer: Is revisiting required?
Magkouta, S., Markaki, E., Evangelou, K., Petty, R., Verginis, P., & Gorgoulis, V. G. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.11.003 · Cited by 20
The Potential Role of Senescence As a Modulator of Platelets and Tumorigenesis
Valenzuela, C. A., Quintanilla, R., Moore‐Carrasco, R., & Brown, N. E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00188 · Cited by 18
Sogabe, Y., Seno, H., Yamamoto, T., & Yamada, Y. (2018) · Cancer Science · doi:10.1111/cas.13731 · Cited by 17
Ho, T.-C., Wang, E.-Y., Yeh, K., Jeng, Y., Horng, J.-H., Wu, L., Chen, Y.-T., Huang, H., Hsu, C., Chen, P., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1918028117 · Cited by 25
“This pattern is consistent with the documented pattern induced by senescent hepatocytes in the liver (15, 16).”
ResultVinhaes, C. L., Cruz, L. A. B., Menezes, R. C., do Carmo, T. A., Arriaga, M. B., Queiroz, A. T. L., Barral‐Netto, M., & Andrade, B. B. (2020) · Viruses · doi:10.3390/v12080864 · Cited by 19
Carpenter, V. J., Patel, B. B., Autorino, R., Smith, S. C., Gewirtz, D. A., & Saleh, T. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188424 · Cited by 18
Innate immune cells and their interaction with T cells in hepatocellular carcinoma (Review)
Hong, G., Cai, D., Gong, J., & Lai, X. (2020) · Oncology Letters · doi:10.3892/ol.2020.12319 · Cited by 20
Razavi, A. S., Mohtashami, M., Razi, S., & Rezaei, N. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155772 · Cited by 22
Chen, W., Zhang, W., Chen, M., Yang, C., Fang, T., Wang, H., Reid, L. M., & He, Z. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00714-4 · Cited by 17
Brinkhoff, B., Ostroumov, D., Heemcke, J., Woller, N., Gürlevik, E., Manns, M. P., Longerich, T., Zender, L., Harty, J. T., Kubicka, S., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201343794 · Cited by 18
Self-citationRaouf, S., Weston, C. R., Yucel, N. D., & Reproducibility Project: Cancer Biology (2015) · eLife · doi:10.7554/elife.04105 · Cited by 17
“• These experiments will analyze a minimum of five mice per treatment group, for a total power of between 89.8% and 99.9%.”
InfluentialSenescence and Cancer: In the Name of Immunosuppression
Llanos, S., & Serrano, M. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.015 · Cited by 17
“This process, known as senescence surveillance or clearance, contributes to prevent tumor initiation (Kang et al., 2011) and also participates in the regression of cancers that have undergone p53-mediated senescence (Xue et al., 2007).”
BackgroundThe Hippo-YAP Pathway Regulates 3D Organ Formation and Homeostasis
Ishihara, E., & Nishina, H. (2018) · Cancers · doi:10.3390/cancers10040122 · Cited by 17
“It has been reported that oncogene-induced senescent hepatocytes secrete chemo- and cytokines and are subject to immune-mediated clearance (designated as “senescence surveillance”), which depends on an intact CD4+ T-cell-mediated adaptive immune response [15].”
BackgroundShih, Y., Shang, H., Chen, Y., Hsueh, S., Chou, H.-M., Lu, H., Lee, M., Hou, H., Chuang, Y., Lee, M., et al. (2019) · Environmental Toxicology · doi:10.1002/tox.22732 · Cited by 17
Inhibition of tyrosine kinase Fgr prevents radiation-induced pulmonary fibrosis (RIPF)
Mukherjee, A., Epperly, M. W., Fisher, R., Hou, W., Shields, D. S., Huq, M. S., Pifer, P. M., Mulherkar, R., Wilhite, T. J., Wang, H., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01538-3 · Cited by 17
“We quantitated the chemokine levels in the media using chemokine array [19].”
MethodLaliberté, C., Bossé, B., Bourdeau, V., Prieto, L. I., Perron-Deshaies, G., Vuong, N., Igelmann, S., Aguilar, L. C., Oeffinger, M., Baker, D. J., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12051089 · Cited by 22
“The SASP is thought to alert the immune system, which allows the elimination of damaged cells [5].”
BackgroundChen, M., Chen, W., Sun, S., Lu, Y., Wu, G., Xu, H., Yang, H., Li, C., He, W., Xu, M., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.08.034 · Cited by 17
“Hepatocytes overexpressing RAS rapidly undergo oncogene-induced senescence, which is accompanied by senescence-associated secretory phenotype (SASP) factors that activate the immune response, thereby inhibiting HCC [9].”
Aging and Lifestyle Modifications for Preventing Aging‐Related Diseases
Li, Q., Zhang, H., Xiao, N., Liang, G., Lin, Y., Yang, X. Y., Yang, J., Qian, Z., Fu, Y., Zhang, C., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202402797rr · Cited by 20
The induction of the fibroblast extracellular senescence metabolome is a dynamic process
James, E. N., Bennett, M. H., & Parkinson, E. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-29809-5 · Cited by 18
Zang, L., Wang, J., Ren, Y., Liu, W., Yu, Y., Zhao, S., Otkur, W., Zhao, Y., Hayashi, T., Tashiro, S., et al. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.11.014 · Cited by 16
Reich, T. R., Schwarzenbach, C., Vilar, J. B., Unger, S., Mühlhäusler, F., Nikolova, T., Poplawski, A., Baymaz, H. I., Beli, P., Christmann, M., et al. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03864-0 · Cited by 18
Tsilimigras, D. I., Ntanasis‐Stathopoulos, I., Moris, D., & Pawlik, T. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-59038-3_14 · Cited by 17
Jiang, Z., Cheng, L., Wu, Z., Zhou, L., Wang, H., Hong, Q., Wu, Q., Long, Y., Huang, Y., Xu, G., et al. (2022) · EMBO Reports · doi:10.15252/embr.202154275 · Cited by 17
“Mutant KRAS and endogenous wild-type p53 were shown to induce cellular senescence that limits liver cancer development in pre-malignant hepatocytes, depending on an intact CD4 + T cell-mediated adaptive immune response (Kang et al , 2011; Mehta et al , 2021), which is absent in our iHCC model.”
Recent Advances in Senolysis for Age-Related Diseases
Aratani, S., & Nakanishi, M. (2023) · Physiology · doi:10.1152/physiol.00003.2023 · Cited by 19
Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers
Hochnadel, I., Kossatz-Boehlert, U., Jedicke, N., Lenzen, H., Manns, M. P., & Yevsa, T. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1359362 · Cited by 20
“However, several studies indicate that HCC cells are resistant to TRAIL-induced apoptosis.101,102 Other therapies target growth factors, among them the insulin-like growth factor (IGF), which is often found overexpressed in HCC.”
BackgroundInfluentialSelf-citationCellular senescence in cancer: Friend or fraud?
Chen, Q., Liu, J., Wu, J., Xiang, X., Zhou, X., Mi, J., Wei, J., Zou, X., & Wu, A. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101363 · Cited by 20
Electrophilic compound screening identifies GPX4-dependent ferroptosis as a senescence vulnerability
D’Ambrosio, M., White, M. E. H., Gavriil, E.-S., Bousset, L., Birch, J., Gruevska, A., Pasquini, E., Colucci, M., Fong, W., Mosole, S., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-01921-z · Cited by 17
“To this end, we analysed a model of cancer initiation in the liver in which OIS is induced in hepatocytes via transposon-induced expression of oncogenic NRAS (NRAS G12V ) 53,54 (Fig.”
Self-citationPalazzo, A., Hernández‐Vargas, H., Goehrig, D., Médard, J., Vindrieux, D., Flaman, J., & Bernard, D. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215850 · Cited by 17
Targeting senescent cells in atherosclerosis: Pathways to novel therapies
Tian, Y., Shao, S., Feng, H., Zeng, R., Li, S., & Zhang, Q. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102502 · Cited by 16
Immune senescence: A key player in cancer biology
Yang, Y., Fan, L., Li, M., & Wang, Z. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.12.001 · Cited by 16
Rudalska, R., Harbig, J., Förster, M., Woelffing, P., Esposito, A., Kudolo, M., Botezatu, A., Haller, V., Janssen, N., Holzmayer, S. J., et al. (2025) · Nature Cancer · doi:10.1038/s43018-024-00899-7 · Cited by 22
Self-citationSenescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control
Belenki, D., Richter‐Pechańska, P., Shao, Z., Bhattacharya, A., Lau, A., de Freitas, J. A. N. L. F., Kandler, G., Hick, T., Cai, X., Scharnagl, E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57429-x · Cited by 16
Reviewing the function of macrophages in liver disease
Chen, L., Guillot, A., & Tacke, F. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2508963 · Cited by 16
“Effective clearance of these senescent cells depends on macrophages and CD4 + T cells, with CCR2 + monocytes playing a key role in cancer surveillance [133].”
Self-citationSenescence in RASopathies, a possible novel contributor to a complex pathophenoype
Engler, M., Fidan, M., Nandi, S., & Cirstea, I. C. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111411 · Cited by 16
The two facets of gp130 signalling in liver tumorigenesis
Schmidt‐Arras, D., Galun, E., & Rose‐John, S. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00861-0 · Cited by 15
In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma
Younger, N. T., Wilson, M. L., Lyons, A. M., Jarman, E. J., Meynert, A. M., Grimes, G. R., Gournopanos, K., Waddell, S. H., Tennant, P. A., Wilson, D. H., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2556 · Cited by 15
“In experimental models, expression of mutant RAS in the adult liver is weakly oncogenic and normally insufficient to initiate ICC formation; rather, mutant cells undergo oncogene-induced senescence and are removed from the liver by immune clearance (30).”
BackgroundCai, D., Zhao, Z., Hu, J., Dai, X., Zhong, G., Gong, J., & Qi, F. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.836080 · Cited by 17
“found that senescent cells stimulated the strong response of CD4 T cells in the liver of mice with activated Ras expression (17).”
BackgroundSIRT1 inhibition‐induced senescence as a strategy to prevent prostate cancer progression
Huang, S., Rivas, P., Yang, X., Lai, Z., Chen, Y., Schadler, K., Hu, M., Reddick, R. L., Ghosh, R., & Kumar, A. P. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23412 · Cited by 16
Mitochondria in cell senescence: A Friend or Foe?
Chen, Q., Young, L. H., & Barsotti, R. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.02.019 · Cited by 15
Kirchner, V. A., Badshah, J. S., Hong, S. K., Martinez, O. M., Pruett, T. L., & Niedernhofer, L. J. (2023) · Transplantation · doi:10.1097/tp.0000000000004838 · Cited by 16
Virus Infection, Inflammation and Prevention of Cancer
Woller, N., & Kühnel, F. (2013) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-38965-8_3 · Cited by 16
Self-citationSinha, V. C., Qin, L. F., & Li, Y. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0481-t · Cited by 18
Francica, P., Aebersold, D. M., & Medová, M. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.08.022 · Cited by 16
Frey, B., Derer, A., Scheithauer, H., Wunderlich, R., Fietkau, R., & Gaipl, U. S. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-39406-0_7 · Cited by 16
“Therefore, the SASP is supposed to also act as a danger signal for the immune system aiming to eradicate potentially transformed or damaged cells in a CD4+ T cell and macrophage-dependent manner [78].”
BackgroundStromal and Immune Drivers of Hepatocarcinogenesis
Saviano, A., Roehlen, N., Virzì, A., Suarez, A. A. R., Hoshida, Y., Lupberger, J., & Baumert, T. F. (2019) · Molecular and translational medicine · doi:10.1007/978-3-030-21540-8_15 · Cited by 20
Park, M. H., Choi, J. E., Kim, J.-R., & Bae, Y. K. (2021) · Pathology & Oncology Research · doi:10.3389/pore.2021.1609795 · Cited by 16
Overcoming Immune Therapy Resistance in Cancer Through Innate Immune Reprogramming
Mandracci, G., Soliman, N., & Khawanky, N. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199554 · Cited by 15
“Senescent cancer cells secrete a distinct profile of cytokines, chemokines, and immune modulators collectively known as the senescence-associated secretory phenotype (SASP) [100,101].”
Senescent macrophages in tumor: phenotypes, roles, and interventions
Shen, W., Huang, Y., Yang, X., Zhang, Y., Pan, Y., Xiao, Y., Wang, J., Wang, C., Mao, W., & Zhao, A. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08000-5 · Cited by 17
“For example, SASP secreted by precancerous hepatocytes after senescence activates the NF-κ B signaling pathway, induces the expression of GM-CSF, Arg1, and IL-6, and signi fi cantly enhances CD4 ⁺ T cell-mediated “ senescence surveillance ” [166, 167].”
Metadata
- Authors
- Kang, T.-W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., Iken, M., Vucur, M., Weiss, S., Heikenwalder, M., Khan, S., Gil, J., Bruder, D., Manns, M., Schirmacher, P., Tacke, F., Ott, M., Luedde, T., Longerich, T., Kubicka, S., & Zender, L.
- Affiliations
- Helmholtz Centre for Infection Research (DE)
- Medizinische Hochschule Hannover (DE)
- Center for Experimental and Clinical Infection Research (DE)
- Universitätsklinikum Aachen (DE)
- Imperial College London (GB)
- Heidelberg University (DE)
- Kreiskliniken Reutlingen (DE)
- Corresponding author
- Zender, Lars
- ORCID
- Venue
- Nature
- Published
- 2011-11
- Volume
- 479
- Issue
- 7374
- Pages
- 547-551
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2042140414
- Cited by
- 1,621
- References
- 22
- Citations by year
- 2026: 93 · 2025: 127 · 2024: 154 · 2023: 140 · 2022: 148 · 2021: 139 · 2020: 137 · 2019: 103 · 2018: 110 · 2017: 99 · 2016: 84 · 2015: 78 · 2014: 72 · 2013: 84 · 2012: 49
- FWCI
- 45.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- oncogene-induced senescence, cellular senescence, hepatocytes, hepatocellular carcinoma, tumor surveillance, CD4+ T cells, tumor antigens, Th1 cells, monocytes/macrophages, tumor suppression, cancer prevention, cancer vaccines
- MeSH terms
- Animals, Antigens, Neoplasm, Carcinoma, Hepatocellular, Humans, Immunologic Surveillance, Liver, Liver Neoplasms, Phagocytosis, Precancerous Conditions, Genes, ras, CD4-Positive T-Lymphocytes, Mice, SCID, Cellular Senescence, Disease Progression, Cancer Vaccines, Hepatocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.